“…In particular, mutations in RBD that retain its structural integrity and function (ACE2-binding) may escape neutralizing antibodies by altering the binding surface either in composition or in conformation, or both (Weisblum et al, 2020 ; Harvey et al, 2021 ; Liu et al, 2021 ; Starr et al, 2021 ). In the past months, strains, such as the lineage B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.1.529, referred to as the Alpha, Beta, Gamma, Delta, and Omicron variant by the World Health Organization, have caused outbreaks and concerns about how these variants, the Omicron in particular (Viana et al, 2022 ), could change the course of the pandemic due to their high virulence and their general resistance against antibodies and vaccines that were developed using previous strains (Hoffmann et al, 2021 ; Planas et al, 2021 ; Wang et al, 2021 ; Bolze et al, 2022 ). Given the large number of active cases, it is reasonable to assume that more escape mutants are almost certain to emerge.…”